Alliance Pharma (APH) is in the news today as it has announced an $11.5 million (£7.5 million) acquisition of all existing rights to the ‘Syntometrine’ drug from industry major Novartis
We can reveal that Nigel Wray – the man known as Britain’s Buffett – has on the back of this added to his material stake in the company. Wray argues
on Shareprophets | CommentsFiled under: